1. Home
  2. IBRX vs AVAV Comparison

IBRX vs AVAV Comparison

Compare IBRX & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.35

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

HOLD

Current Price

$149.24

Market Cap

8.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
AVAV
Founded
2014
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.6B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
IBRX
AVAV
Price
$7.35
$149.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
17
Target Price
$12.57
$316.88
AVG Volume (30 Days)
11.7M
1.3M
Earning Date
05-08-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
38.71
N/A
EPS
N/A
N/A
Revenue
$113,288,000.00
N/A
Revenue This Year
$88.59
$135.55
Revenue Next Year
$131.15
$14.90
P/E Ratio
N/A
N/A
Revenue Growth
668.31
N/A
52 Week Low
$1.95
$150.36
52 Week High
$12.43
$417.86

Technical Indicators

Market Signals
Indicator
IBRX
AVAV
Relative Strength Index (RSI) 51.85 36.29
Support Level $6.69 N/A
Resistance Level $8.54 $220.08
Average True Range (ATR) 0.40 10.96
MACD 0.04 -3.51
Stochastic Oscillator 89.02 6.32

Price Performance

Historical Comparison
IBRX
AVAV

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

Share on Social Networks: